Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD - mixed treatment comparisons of clinical efficacy.

Stynes, Gillian

Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD - mixed treatment comparisons of clinical efficacy. [electronic resource] - Respiratory research Feb 2015 - 25 p. digital

Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review

1465-993X

10.1186/s12931-015-0184-8 doi


Administration, Inhalation
Adrenal Cortex Hormones--administration & dosage
Adrenergic beta-2 Receptor Agonists--administration & dosage
Aged
Androstadienes--administration & dosage
Bayes Theorem
Benzyl Alcohols--administration & dosage
Bronchodilator Agents--administration & dosage
Budesonide, Formoterol Fumarate Drug Combination--administration & dosage
Chlorobenzenes--administration & dosage
Disease Progression
Drug Administration Schedule
Female
Fluticasone-Salmeterol Drug Combination--administration & dosage
Forced Expiratory Volume
Humans
Lung--drug effects
Male
Middle Aged
Pulmonary Disease, Chronic Obstructive--diagnosis
Randomized Controlled Trials as Topic
Recovery of Function
Risk Factors
Time Factors
Treatment Outcome